Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fidia Spa ( (IT:FDA) ) has shared an update.
Fidia S.p.A. reported that Global Growth Holding Limited converted four bonds from the sixth tranche of the company’s reserved convertible bond loan, resulting in the issuance of 4,000,000 new shares at a conversion price of €0.01 per share. The new shares are admitted to trading, and the related share capital increase will be formally recorded with the Turin Companies Register as required by law.
Following this conversion, the subscription of the convertible bond loan has reached a nominal €1.5 million, with €1.33 million of the related capital increase already subscribed and 17 bonds in the sixth tranche still to be converted. As a result, Fidia’s share capital rises by €40,000 to €11,177,761.90, and its total number of shares increases to 92,542,927, further advancing the company’s structured recapitalisation and funding process with its reference investor.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading provider of high-performance integrated milling systems, numerical controls and CAM software. The group focuses on complex-shape machining for mould-making in the automotive industry and for aerospace applications, offering end-to-end solutions that cover the entire milling process from programming to finished product.
YTD Price Performance: -90.83%
Average Trading Volume: 2,374,058
Technical Sentiment Signal: Strong Sell
Current Market Cap: €785.1K
Learn more about FDA stock on TipRanks’ Stock Analysis page.